A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)
Clinical trial NCT06118333 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06118333
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-04
- Primary completion
- 2026-11-01
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.